Alphatec Holdings, Inc.
Financials
Valuation Metrics
Alphatec Holdings, Inc.'s Market Cap is $1.12B. At end of 2025 it was $3.16B. Ranked #2086 of 3,116 in US market (top 67%), #802 of 1,472 on NASDAQ (top 54%), #131 of 203 in Health Care Equipment & Services (top 65%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.12B | US#2,086/3,116 Sec#131/203 |
| Revenue | $840M | US#1,973/3,116 Sec#124/203 |
| Net Income | $-87M | US—/3,116 Sec—/203 |
| Total Assets | $797M | US#2,571/3,116 Sec#138/203 |
| Net Assets | $21M | US#2,919/3,116 Sec#194/203 |
| Employees | 913 | US#2,014/3,116 Sec#139/203 |
| Value | ||
| P/B | 52.78x | US—/3,116 Sec—/203 |
| P/S | 1.34x | US#1,327/3,116 Sec#92/203 |
| EV/EBITDA | 50.69x | US#2,455/3,116 Sec#138/203 |
| FCF Yield | 0.44% | US#2,233/3,116 Sec#138/203 |
| Profitability | ||
| ROA | -10.91% | US#2,721/3,116 Sec#164/203 |
| Op. Margin | -3.11% | US#2,459/3,116 Sec#148/203 |
| Revenue Growth | 15.34% | US#704/3,116 Sec#45/203 |
| Financial Health | ||
| Debt Ratio | 3640.41% | US—/3,116 Sec—/203 |
| Total Debt | $594M | US#1,770/3,116 Sec#98/203 |
| FCF | $5M | US#2,257/3,116 Sec#139/203 |
| Cash | $80M | US#2,104/3,116 Sec#128/203 |
| Current Ratio | 2.36x | US#1,304/3,116 Sec#113/203 |
| Net Debt/EBITDA | 15.90x | US#2,498/3,116 Sec#145/203 |
| Performance | ||
| 1Y Return | -61.51% | US#2,627/3,116 Sec#171/203 |
| 1M Return | -27.12% | US#763/3,116 Sec#74/203 |
| From 52W High | -68.61% | US#2,686/3,116 Sec#181/203 |
| 1Y MDD | -69.18% | US#2,921/3,116 Sec#187/203 |
| Trading | ||
| Volume | 11,827,172 shares | US#288/3,116 Sec#13/203 |
| Trading Value | $88M | US#1,034/3,116 Sec#76/203 |
| Per Share | ||
| EPS | $-0.56 | US—/3,116 Sec—/203 |
| BPS | $0.14 | US—/3,116 Sec—/203 |
Company Info
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.